Directing subgroup modeling in phase iii trial designs
Michael LeBlanc (Fred Hutchinson Cancer Research Center, USA)

Statistical analysis plans in phase III all-comers clinical trials with predictive Biomarkers
Shigeyuki Matsui (Institute of Statistical Mathematics, Tokyo)

Keeping clinical risk calculators current
Donna Ankerst (Technische Universitaet Muenchen, Germany)

Discussion of the session’s presentations
John Crowley (Cancer Research & Biostatistics, USA)